Interferon-Induced Transmembrane Protein 1 (IFITM1) Peptide
-
- Target See all IFITM1 products
- IFITM1 (Interferon-Induced Transmembrane Protein 1 (IFITM1))
- Peptide Type
- Synthetic
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-CD225 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- IFITM1 (Interferon-Induced Transmembrane Protein 1 (IFITM1))
- Synonyms
- 9-27 Peptide, CD225 Peptide, DSPA2a Peptide, IFI17 Peptide, LEU13 Peptide, 1110036C17Rik Peptide, Mil-2 Peptide, Mil2 Peptide, interferon induced transmembrane protein 1 Peptide, interferon induced transmembrane protein 1 (9-27) Peptide, Ifitm1 Peptide, IFITM1 Peptide
- Background
- CD225, IFI17, Interferon-induced transmembrane protein 1, Dispanin subfamily A member 2a, DSPA2a, Interferon-induced protein 17, Interferon-inducible protein 9-27, Leu-13 antigen, CD225
- Gene ID
- 8519
- UniProt
- P13164
-